John L. Green

Insider Reports History

Entity
Individual
Location
Merrimack Pharmaceuticals, Inc., One Kendall Square, Suite B7201, Cambridge, MA
Signature
/s/ Evan D. Kearns, Attorney-in-Fact
All insider transactions
Transactions in reports broken out by “transaction date” reported in original SEC filing, see here for transactions aggregated across transaction date

Holdings reported by John L. Green:

Stock Role Class Num Shares Value Price $ Report Date Ownership
Cogent Biosciences, Inc. Chief Financial Officer Stock Option (Right to Buy) 300K Jan 23, 2024 Direct

Insider Reports Filed by John L. Green

Symbol Company Period Transactions Value $ Form Type Date Filed Role
COGT Cogent Biosciences, Inc. Jan 23, 2024 1 $0 4 Jan 25, 2024 Chief Financial Officer
COGT Cogent Biosciences, Inc. Feb 13, 2023 1 $0 4 Feb 15, 2023 Chief Financial Officer
COGT Cogent Biosciences, Inc. Jan 25, 2022 1 $1.11M 4 Jan 27, 2022 Chief Financial Officer